MedTech Dive September 24, 2025
Nick Paul Taylor

Cardiosense’s switch to a leader with experience scaling healthtech companies comes as it works to build on the recent 510(k) clearance of CardioTag.

Name: Eric Meizlish

New title: CEO, Cardiosense

Previous title: CEO, Prendio-BioProcure

Cardiosense has hired Eric Meizlish as CEO to oversee the growth of its recently cleared wearable heart monitor.

The company, which disclosed the appointment last week, has recruited Meizlish to replace co-founder Amit Gupta as CEO. Gupta will continue as chief strategy officer. Cardiosense has made the change as it enters a new phase in its growth, with the focus now on driving sales of the CardioTag heart monitor and launching artificial intelligence models that pair with the device.

Meizlish has experience leading companies through similar...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Medical Devices
The medical device trends doctors can expect to see in 2026
Are Biofeedback Devices the Key to Stopping Senior Stress?
Consolidation trends in the medical device industry in 2026
This Week in European MedTech and HealthTech: 23rd January 2026
Intuitive pushes into cardiac robotic surgery, ASCs

Share Article